Skip to content

Investigating the Local Immune Responses in the Skin after Repeated Hookworm Infection

Investigating the Local Immune Responses in the Skin after Repeated Hookworm Infection - HiBiSki

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57751
Enrollment
5
Registered
2024-04-04
Start date
2025-10-13
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hookworm infection parasitic infection Abdominal worminfection

Interventions

Five volunteers will be exposed to 50 Necator americanus L3 larvae, after which they will be treated with a curative regimen of albendazole after two weeks. Then, they will be inoculated with a lowe

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: 1. Subject is aged >= 18 and

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: 1. Any history, or evidence at screening, of clinically significant symptoms, physical signs or abnormal laboratory values suggestive of systemic conditions, such as cardiovascular, pulmonary, renal, hepatic, neurological, dermatological, endocrine, malignant, haematological, infectious, immune-deficient, psychiatric and other disorders, which could compromise the health of the volunteer during the study or interfere with the interpretation of the study results. These include, but are not limited to, any of the following: • positive HIV, HBV or HCV screening tests; • the use of immune modifying drugs within three months prior to study onset (inhaled and topical corticosteroids and oral anti-histamines exempted) or expected use of such during the study period; • having one of the following laboratory abnormalities: ferritine

Design outcomes

Primary

MeasureTime frame
- Identification of effector cells in the skin by Hyperion Imaging Mass Cytometry after repeated controlled hookworm infections - Association between the macroscopic skin reaction and effector cells present identified by Hyperion Imaging Mass Cytometry

Secondary

MeasureTime frame
- Measurement of humoral (antibody responses and cytokines) and cellular immunological changes after controlled hookworm infections - Detection of hookworm eggs by faeces microscopy (Kato-Katz) at week 15-16 in volunteers who volunteered to be chronic donors Endpoints for exploratory objectives: - Number of adverse events following exposure(s) to hookworm larvae

Countries

Netherlands

Contacts

Public ContactM. Hoogerwerf

Leids Universitair Medisch Centrum

vaccinonderzoek@lumc.nl071-5265062

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 3, 2026